雅虎香港 搜尋

登入

搜尋結果

  1. hk.finance.yahoo.com › news › global-transplant-box-researchGlobal Transplant Box Research Report 2024: Market to Reach ...

    2024年3月25日 · Rising healthcare expenditure, technological advancements in organ preservation coupled with increasing demand for organ transplants, and increasing collaboration and partnerships among the...

  2. hk.finance.yahoo.com › news › renowned-transplant-surgeonRenowned Transplant Surgeon and Medical Innovator, Dr. ...

    2024年4月1日 · LOS ANGELES, April 01, 2024--(BUSINESS WIRE)--Dr. Robert Mendez, a pioneering figure in the field of organ transplantation and organ donation, passed away on March 29, 2024, leaving behind a...

  3. hk.finance.yahoo.com › news › acrobiosystems-launches-3d-organACROBiosystems Launches 3D Organoid Solutions, Propelling ...

    2024年4月10日 · By leveraging its proprietary organoid research and development platform, the company is seeking to continuously expand its solutions by creating organoids like retina, skin, and lung; thereby...

  4. hk.finance.yahoo.com › news › harvard-apparatus-regenerativeHarvard Apparatus Regenerative Technology Reports Fourth ...

    2024年4月2日 · Holliston, MA, April 02, 2024 (GLOBE NEWSWIRE) -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat ...

  5. hk.finance.yahoo.com › news › xortx-welcomes-member-boardXORTX Welcomes New Member to the Board of Directors - 雅虎財經

    2024年4月8日 · CALGARY, Alberta, April 08, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, welcomes Abigail Jenkins, a biotech industry veteran with deep experience with the commercialization of ...

  6. hk.finance.yahoo.com › news › affini-t-therapeutics-presentsAffini-T Therapeutics Presents Preclinical Data from its ...

    2024年4月7日 · Presenting Author: Gary Shapiro, Ph.D., VP Biology Discovery, Affini-T Therapeutics Summary: The tumor suppressor TP53 is the most frequently mutated gene across human cancers, with a highly...

  7. hk.finance.yahoo.com › news › surrozen-publishes-studySurrozen Publishes Study in 'Respiratory Research' ...

    2024年4月3日 · SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Surrozen, Inc. (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively modulate the Wnt pathway for tissue repair...